Categories AlphaGraphs, Consumer, Earnings
Key highlights from Kimberly-Clark’s (KMB) Q2 2023 earnings results
Kimberly-Clark Corporation (NYSE: KMB) reported second quarter 2023 earnings results today.
Net sales were $5.1 billion, up 1% year-over-year. Organic sales grew 5%.
Net income attributable to Kimberly-Clark Corporation decreased 77% to $102 million, or $0.30 per share, compared to last year. Adjusted EPS increased 23% to $1.65.
For the full year of 2023, the company expects net sales growth of 0-2% and organic sales growth of 3-5%. Adjusted EPS is expected to increase 10-14% from last year.
Prior performance
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
